Novartis’ remibrutinib bags positive CHMP opinion for chronic urticaria
The oral therapy is aimed at adults with chronic spontaneous urticaria (CSU) who do not respond adequately to H1-antihistamines
The oral therapy is aimed at adults with chronic spontaneous urticaria (CSU) who do not respond adequately to H1-antihistamines
Arcellx develops innovative immunotherapies for cancer and other incurable diseases
The innovative eyedrop targets inflammation and pain following ocular surgery
Prostate cancer is one of the fastest-growing cancers in India, with approximately 37,948 new cases each year
The funding comes under the AHG Catalysing Innovation Awards, part of the Addiction Healthcare Goals programme led by the Office for Life Sciences
DeslaFlex is an innovative antidepressant formulation developed by Spektus using the proprietary Flexitab oral drug-delivery platform
The approval marks a major advance in targeted treatment for this rare, chronic autoimmune disease, offering twice-yearly maintenance dosing after two initial loading doses
ADQUEY’s approval opens the door to a new alternative for millions of Americans struggling with atopic dermatitis
Under the deal, Uniphar will serve as LYMPHIR’s exclusive distribution partner across designated Western and Eastern European territories
Subscribe To Our Newsletter & Stay Updated